Login
|
Register
News
Media
Insights
Peer Exchange
OncNurse TV
Webinars
Podcasts
Resources
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Gynecologic Cancers
Supportive Care
Blood Cancers
Prevention
Genetics
Nurse Navigation
Immuno-Oncology
Drug Safety
Skin Cancer/Melanoma
Brain Cancer
Childhood/AYA Cancer
Head and Neck Cancers
Adverse Event Management
Contributors
Conferences
Partners
Advocacy
Associations
Schools of Nursing
Publications
CE
Register now to learn about a new option for relapsed or refractory follicular lymphoma
Facing COVID-19's Challenges to Care for the Caregiver
BY CHRISTIE M. SANTURE, BSN, RN, OCN AND LYNNE O'CONNOR, MSN, RN
Diarrhea Management in HER2+ Breast Cancer
BY PATRICIA JAKEL, MN, RN, AOCN
Forged Through Fire: Nurses Are More Needed Than Ever Before
BY JANN BUDIMAN, BSN, RN, BMTCN
Immunotherapy Moves to SCLC, But Chemotherapy Is Still a Mainstay
BY BETH SANDY, MSN, CRNP
Trial To Evaluate Eprenetapopt-Azacytidine Combo in TP53+ MDS Completes Enrollment
BY GUILLERMO GARCIA-MANERO, MD
Tivozanib Tolerability Shows Potential Advantage for Patients with Advanced RCC
BY KRISTIE L. KAHL
Patient Education for Oral Therapies Is Crucial
BY PATRICIA JAKEL, MN, RN, AOCN
Don't Shy Away from the Sex Talk With Cancer Survivors
BY DON S. DIZON, MD, FACP
Struggles in Full Biomarker Testing for Lung Cancer
BY LYNETTE M. SHOLL, MD
Radiation Is Essential in Lung Cancer Treatment
BY TERENCE T. SIO, MD, MS
<< Prev Page
Next Page >>
External Resources
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
OncNurse Resources
Newsroom
Continuing Education
Discussions
Web Exclusives
About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.